Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Renal Cell Carcinoma (RCC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06265285
What this trial is testing

Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program

Who this might be right for
Advanced Esophageal Squamous Cell CarcinomaAdvanced Renal Cell CarcinomaClinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8+28 more
Mayo Clinic 50
Early research (Phase 1)Active Not RecruitingNCT03212404
What this trial is testing

Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers

Who this might be right for
Lung NeoplasmsCarcinoma, Non-Small-Cell LungCarcinoma, Small Cell+10 more
Checkpoint Therapeutics, Inc. 272
Early research (Phase 1)Study completedNCT01218555
What this trial is testing

Study of Everolimus (RAD001) in Combination With Lenalidomide

Who this might be right for
Solid Organ MalignanciesAdenoidcystic CarcinomaNeuroendocrine Tumors
Emory University 44
Not applicableUnknownNCT03734614
What this trial is testing

Preventive Effects of Aspirin as Adjuvant Therapy in Patients With Locally Advanced Renal Cell Carcinoma

Who this might be right for
Aspirin as Adjuvant Therapy in Patients With Surgically Treated High Risk Renal Cell Carcinoma
RenJi Hospital 260
Testing effectiveness (Phase 2)Study completedNCT00448721
What this trial is testing

A Phase II Trial of Perifosine Following Tyrosine Kinase Inhibitor (TKI) - Failure in Patients With Renal Cancer

Who this might be right for
Renal Cell Carcinoma
AEterna Zentaris 24
Large-scale testing (Phase 3)Study completedNCT02420821
What this trial is testing

Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC)

Who this might be right for
Renal Cell Carcinoma
Hoffmann-La Roche 915
Not applicableUnknownNCT04107168
What this trial is testing

Microbiome Immunotherapy Toxicity and Response Evaluation

Who this might be right for
MelanomaRenal CancerLung Cancer
CCTU- Cancer Theme 1,800
Early research (Phase 1)Ended earlyNCT04152018
What this trial is testing

Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors.

Who this might be right for
Squamous Cell Carcinoma of the Head and NeckRenal Cell CarcinomaOvarian Cancer+8 more
Pfizer 85
Testing effectiveness (Phase 2)UnknownNCT04995016
What this trial is testing

Pembrolizumab and Axitinib as Neoadjuvant Therapy for Locally Advanced Non-metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaClear Cell Renal Cell Carcinoma
Tianjin Medical University Second Hospital 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT04140526
What this trial is testing

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

Who this might be right for
Non Small Cell Lung CancerAdvanced Solid TumorMetastatic Melanoma+16 more
OncoC4, Inc. 733
Early research (Phase 1)Active Not RecruitingNCT04514484
What this trial is testing

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

Who this might be right for
Advanced Differentiated Thyroid Gland CarcinomaAdvanced Head and Neck CarcinomaAdvanced Hepatocellular Carcinoma+60 more
National Cancer Institute (NCI) 8
Early research (Phase 1)Active Not RecruitingNCT05239143
What this trial is testing

P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors

Who this might be right for
Breast CancerOvarian CancerNon Small Cell Lung Cancer+6 more
Poseida Therapeutics, Inc. 180
Testing effectiveness (Phase 2)Ended earlyNCT00975806
What this trial is testing

Study of Lenalidomide in Combination With Sunitinib to Evaluate the Safety and Efficacy in Patients With Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Celgene 16
Early research (Phase 1)Ended earlyNCT06299163
What this trial is testing

NM32-2668 in Adult Patients With Selected Advanced Solid Tumors

Who this might be right for
Ovarian CarcinomaFallopian Tube CarcinomaPeritoneal Carcinoma+10 more
Numab Therapeutics AG 11
Testing effectiveness (Phase 2)UnknownNCT02072044
What this trial is testing

Phase II Study of Anlotinib in Patients With Advanced Renal Cell Carcinoma That Have Failed Or Are Intolerant To TKIs Therapy

Who this might be right for
Renal Cell Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 60
Not applicableStudy completedNCT01381614
What this trial is testing

Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (IHCIS)

Who this might be right for
Carcinoma, Renal Cell
GlaxoSmithKline 1
Testing effectiveness (Phase 2)UnknownNCT01577784
What this trial is testing

Pazopanib in Second-line Therapy in Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Associació per a la Recerca Oncologica, Spain 27
Early research (Phase 1)Not Yet RecruitingNCT07686744
What this trial is testing

Neoantigen Peptide Vaccine Plus Pembrolizumab in Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaAdvancedRecurrent+1 more
Jian Lin 8
Not applicableStudy completedNCT02533258
What this trial is testing

Post-Marketing Surveillance Study To Observe INLYTA® Treatment Dosing Pattern, Safety And Effectiveness In Taiwan Real World Routine Practice

Who this might be right for
Renal Cell Carcinoma
Pfizer 13
Testing effectiveness (Phase 2)UnknownNCT02774200
What this trial is testing

A One-arm Exploratory Clinical Research Program Study of Apatinib in Advanced Metastatic Renal Cell Carcinoma Patients.

Who this might be right for
Metastatic Renal Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital 20
Next Page